While countless scientific and medical research is simultaneously carried out all over the world to find the cancer cure, others opt to take a slightly different route. A former medical practitioner is making headlines for reportedly developing a natural cancer treatment mainly composed of dried herbs and mushrooms.
This story came to light after cancer patient Chris Rosenau told FOX4 of her experience in taking a herbs and mushrooms mixture referred to as “mud.” It is reportedly developed by former medical practitioner Ken Crawford, who Rosenau first heard of through a Facebook group.
Rosenau was diagnosed with breast cancer at an early stage. “It was still a two-centimeter mass. It was right on the border of stage one and stage two,” the patient recalled. She, however, preferred to undergo a natural treatment being offered by Crawford. He reportedly admitted that his herbal treatment mixture was still being experimented at the time while he also told the news outlet that he developed the mixture after reading through 30,000 medical journal articles. Later on in the article, Crawford stands by the effectiveness of his concoction and claims that it showed positive results on close friends who were diagnosed with cancer.
Crawford’s treatment reportedly cost Rosenau $17,000. She was also required to shoulder Crawford’s travel and accommodation expenses to personally demonstrate how to whip up the mixture. But she is not allowed to reveal herbs and types of mushrooms in due to a non-disclosure agreement that purportedly discouraged her from telling her oncologist about the natural treatment.
Rosenau discontinued the natural treatment in less than two weeks after consistently experiencing diarrhea and losing 10 pounds. "After one glass, I just felt horrible, nausea, headachy," she explained. "I stayed on the protocol for a week and a half and just continued to go downhill.”
Crawford has yet to fully refund Rosenau, though, the latter says she is not giving it much hope. Meanwhile, authorities are already getting involved as FOX4 confirmed the Federal Drug Administration and the Kansas Attorney General's Office have started their investigation.


NASA Faces Major Workforce Reduction as 20% of Employees Prepare to Leave
Cogent Biosciences Soars 120% on Breakthrough Phase 3 Results for Bezuclastinib in GIST Treatment
China vs. NASA: The New Moon Race and What's at Stake by 2030
Is space worth the cost? Accounting experts say its value can’t be found in spreadsheets
SpaceX Pivots Toward Moon City as Musk Reframes Long-Term Space Vision
Neuralink Plans High-Volume Brain Implant Production and Fully Automated Surgery by 2026
Tabletop particle accelerator could transform medicine and materials science
Trump Administration Releases New UFO Files and Apollo Mission Records
Blue Origin’s New Glenn Achieves Breakthrough Success With First NASA Mission 



